OpenU54NIDDKClinical trial: Optional / allowed
George M. O’Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NIH Institute/Center · RFA-DK-28-314
Source: Grants.gov · View original posting ↗
- AwardWhat a single award can be worth — the funder's published per-award amount or floor–ceiling range.
- Up to $750K
- DeadlineFinal application due date.
- Feb 1, 2027
- Letter of intentDue date for the letter of intent (a short pre-application some funders require or request before the full proposal).
- —
- MechanismNIH activity code — the grant type (R01 research project, R21 exploratory, K series career development, F series fellowship, …).
- U54
- DurationMaximum project period for a single award.
- —
- Expected awardsHow many awards the funder anticipates making under this opportunity.
- 5
- Funding cycleHow often the program accepts applications (annual, multiple cycles per year, rolling, or one-time).
- One-time
- Open dateWhen applications open (or opened).
- Nov 3, 2026
- Total fundingThe overall pool the funder expects to commit across ALL awards under this opportunity — not what one project receives.
- $5.2M total
- Clinical trialWhether proposed projects must, may, or must not include a clinical trial.
- Optional / allowed
GovernmentHigher educationNonprofitSmall businessForeign entities
Description
This Notice of Funding Opportunity (NOFO) seeks support for continuation of the NIDDK George M. O'Brien Urology Cooperative Research Centers (U54). The Urology Cooperative Research Centers foster impactful, multi-disciplinary research through collaborations within and outside the Centers and serve as a national resource for the urology research community.